Annual Drug Patent Expirations for ANORO+ELLIPTA Anoro Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are fifteen patents…
The post New patent expiration for Glaxosmithkline drug ANORO…
New patent expiration for Glaxosmithkline drug ANORO ELLIPTA Read Post »
Annual Drug Patent Expirations for BREO+ELLIPTA Breo Ellipta is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from two suppliers. There are…
The post New patent expiration for Glaxo Grp drug BREO ELLIPTA appeared first on…
New patent expiration for Glaxo Grp drug BREO ELLIPTA Read Post »
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in France. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutical …
Which pharmaceutical companies have the most SPCs in France? Read Post »
Annual Drug Patent Expirations for NUZYRA Nuzyra is a drug marketed by Paratek Pharms Inc and is included in two NDAs. It is available from one supplier. There are ten…
The post New patent for Paratek Pharms drug NUZYRA appeared first on DrugPatentWatc…
Annual Drug Patent Expirations for NUZYRA Nuzyra is a drug marketed by Paratek Pharms Inc and is included in two NDAs. It is available from one supplier. There are ten…
The post New patent for Paratek Pharms drug NUZYRA appeared first on DrugPatentWatc…
Annual Drug Patent Expirations for BYLVAY Bylvay is a drug marketed by Albireo and is included in one NDA. It is available from one supplier. There are eight patents protecting…
The post New patent for Albireo drug BYLVAY appeared first on DrugPatentWa…
Annual Drug Patent Expirations for BYLVAY Bylvay is a drug marketed by Albireo and is included in one NDA. It is available from one supplier. There are eight patents protecting…
The post New patent for Albireo drug BYLVAY appeared first on DrugPatentWa…
Annual Drug Patent Expirations for SOLUPREP Soluprep is a drug marketed by 3m Health Care and is included in one NDA. It is available from one supplier. There is one…
The post New patent for 3m Health drug SOLUPREP appeared first on DrugPatentWatch – M…
Annual Drug Patent Expirations for QVAR+REDIHALER Qvar Redihaler is a drug marketed by Norton Waterford and is included in one NDA. It is available from one supplier. There are ten…
The post New patent for Norton Waterford drug QVAR REDIHALER appeared …
New patent for Norton Waterford drug QVAR REDIHALER Read Post »
Annual Drug Patent Expirations for XHANCE Xhance is a drug marketed by Optinose Us Inc and is included in one NDA. It is available from one supplier. There are thirteen…
The post New patent for Optinose Us drug XHANCE appeared first on DrugPatentWatch …
Get new actionable insights and updates from BiotechBlog
